MedTrace Logo

PRF for Treating Maxillary Gingival Recession

NCT05267015 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-03-04

No results posted yet for this study

Summary

This is a split-mouth, randomized, controlled clinical trial that aims to evaluate the clinical efficacy of platelet-rich fibrin (PRF) membranes in conjunction with coronally advanced flap (CAF) in treating maxillary gingival recession defects.

Conditions

  • Gingival Recession

Interventions

PROCEDURE

Gingival coverage using coronally advanced flap and a connective tissue graft

A coronally advanced flap is applied for recession coverage in the maxilla in a split-mouth randomized trial using a subepithelial connective tissue graft

PROCEDURE

Gingival coverage using coronally advanced flap and platelet rich fibrin membranes

A coronally advanced flap is applied for recession coverage in the maxilla in a split-mouth randomized trial using platelet rich fibrin membranes

Sponsors & Collaborators

  • Arab American University (Palestine)

    lead OTHER

Principal Investigators

  • Mahmoud F Abu-Ta'a, Periodontist · Head of Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-03
Primary Completion
2021-08-15
Completion
2021-11-14

Countries

  • Palestinian Territories

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05267015 on ClinicalTrials.gov